Alpa Laboratories Ltd's earnings have declined by -6.2%, whereas share price has appreciated 13.6% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Alpa Laboratories Ltd share price has appreciated 22.9% annually (CAGR) over the past ten years.
Data is not available for this company.
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise.
The company manufactures a spectrum of products such as ethical drugs, generic drugs, over the counter
The company manufactures a spectrum of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products. These products are manufactured in various dosage forms such as injectables (vials/ampoules both liquid and dry), tablets, capsules, eye/ear drops, ointment and creams. The company markets these products under the trademark 'Alpa'.
The company manufactures formulations for other major pharmaceutical companies namely Cipla, Zydus Cadila, Lupin, Glenmark, Genom, Biotech Jenburkt etc. Alpa Laboratories exports a wide range of products to countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Sri Lanka, etc.
The company manufactures a wide range of drugs and formulation for human use. These drugs cater to therapeutic segments such as antibacterial, anti-inflammatory, anti-allergic, anti-histaminics and anti-infective are among others. It manufactures products such as Alquin, optamycin, Amoxycillin capsules and many more
Alpha Labs also manufactures veterinary products such as diphen and grotax-250 among others.
1988- Alpa Laboratories was incorporated as private limited company.
1997- The company set up a manufacturing facility at Pigdamber, Indore.
1998- It was converted into public limited enterprise
1999- The company started of commercial production of the unit.
2001- Alpha received WHO GMP Certification for its manufacturing facilities. It entered into an agreement with Plethico Pharmaceuticals for contract manufacturing. The companyâ€™s Pigdamber unit were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02.
2003- The Pigdamber unit received ISO 9001: 2000 certification. The same year company started exporting its veterinary products. It registered 7 veterinary products in Sudan.
2006- The company established veterinary division with a new face and ethical promotion of its veterinary products launched in 5 states. Alpha also launched Ethical division for its human products.
2007- Alpa Laboratories collaborated with Vhermann Pharmaceutical Inc Philippines for distribution of its products international marketing
Alpa Laboratories is engaged in developing new products and services to strengthen its presence. The company also plans to explore untapped markets.